<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005464A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005464</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14004504</doc-number><date>20120313</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>N</subclass><main-group>5</main-group><subgroup>10</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>N</subclass><main-group>5</main-group><subgroup>1037</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>600  1</main-classification></classification-national><invention-title id="d0e43">STUDYING DOSIMETRIC IMPACT OF MOTION TO GENERATE ADAPTIVE PATIENT-SPECIFIC MARGINS IN EBRT PLANNING</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61452797</doc-number><date>20110315</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Bharat</last-name><first-name>Shyam</first-name><address><city>Creve Coeur</city><state>MO</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Bzdusek</last-name><first-name>Karl Antonin</first-name><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Parikh</last-name><first-name>Parag Jitendra</first-name><address><city>St. Louis</city><state>MO</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Noel</last-name><first-name>Camille Elizabeth</first-name><address><city>St. Louis</city><state>MO</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Bharat</last-name><first-name>Shyam</first-name><address><city>Creve Coeur</city><state>MO</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Bzdusek</last-name><first-name>Karl Antonin</first-name><address><city>Madison</city><state>WI</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Parikh</last-name><first-name>Parag Jitendra</first-name><address><city>St. Louis</city><state>MO</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Noel</last-name><first-name>Camille Elizabeth</first-name><address><city>St. Louis</city><state>MO</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>KONINKLIJKE PHILIPS N.V.</orgname><role>03</role><address><city>EINDHOVEN</city><country>NL</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/IB12/51178</doc-number><kind>00</kind><date>20120313</date></document-id><us-371c124-date><date>20130911</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">A treatment planning system (<b>106</b>) for generating patient-specific treatment margins. The system (<b>106</b>) includes one or more processors (<b>142</b>). The processors (<b>142</b>) are programmed to receive a radiation treatment plan (RTP) for irradiating a target (<b>122</b>) over the course of one or more treatment fractions. The RTP including one or more treatment margins around the target (<b>122</b>) and a planned dose distribution for the target (<b>122</b>). The processors (<b>142</b>) are further programmed to receive motion data for at least one of the treatment fractions of the RTP from one or more target surrogates (<b>124</b>), calculate a motion-compensated dose distribution for the target (<b>122</b>) using the motion data and the planned dose distribution, compare the motion-compensated dose distribution to the planned dose distribution, and adjust the treatment margins based on dosimetric differences between the motion-compensated dose distribution and the planned dose distribution.</p></abstract></us-patent-application>